Dhanalakshmi Angappan, MD

My goal is to provide patient-centered care while respecting the values and needs of patients and their family members. I aim to provide reassurance and emotional support while alleviating fear and anxiety.

About Dhanalakshmi Angappan, MD

Dhanalakshmi Angappan, MD, is a pediatric neurologist at Phoenix Children's. She treats the full range of neurological conditions that affect children including headaches, seizures, syncope (fainting), developmental delays, neuroimmunology and demyelinating diseases such a multiple sclerosis.

Dr. Angappan earned her medical degree and completed a medical internship at the Jawaharlal Institute of Postgraduate Medical Education and Research in Puducherry, India. She trained as a pediatric resident at the Postgraduate Institute of Medical Education and Research in Chandigarh, India, and at The MetroHealth System through Case Western Reserve University in Cleveland. Dr. Angappan completed her fellowship training in pediatric neurology at Oregon Health & Science University in Portland, Oregon.

Dr. Angappan is board certified in Neurology by the American Board of Psychiatry and Neurology. She is a member of the American Academy of Neurology, the Child Neurology Society, the American Headache Society and the International Child Neurology Association. She has been a presenter at the American Academy of Neurology annual meetings, as well as conferences hosted by the Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) and the Child Neurology Society.

A committed researcher in the field of pediatric neurology, Dr. Angappan's work has been published in peer-reviewed medical journals including The Lancet, The Lancet Neurology, Children, Frontiers in Pediatrics and the European Journal of Pediatric Neurology.

In her free time, Dr. Angappan enjoys cooking, traveling and spending quality time with her children.

Medical School / Education

Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India

Internship

Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India

Residency

(Pediatrics) Postgraduate Institute of Medical Education and Research, Chandigarh, India

(Pediatrics) The MetroHealth System / Case Western Reserve University, Cleveland, OH

Fellowship

(Pediatric Neurology) Oregon Health & Science University, Portland, OR

Neurology with Special Qualification in Child Neurology

American Board of Psychiatry & Neurology

Professional Affiliations

Member, Child Neurology Society

Member, American Headache Society

Member, American Academy of Neurology

Member, International Child Neurology Association

Jaimie D. Steinmetz, Dhanalakshmi Angappan et al. Global, Regional, and National Burden of Disorders affecting the Nervous System, 1990-2021: A Systematic Analysis for the Global Burden of Disease Study 2021. The Lancet Neurology. March 2024; 23(4):344-381

Austin E Schumacher, Dhanalakshmi Angappan et al. Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950-2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021. The Lancet. March 2024; 403(10440):1989-2056

Mahdi Safdarian, Dhanalakshmi Angappan et al. Global, regional, and national burden of spinal cord injury, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurology. November 2023; 22: 1026-47

Dhanalakshmi Angappan, McKinnon Garrett, Candice Henry, Art Riddle, Jenny Wilson. Pediatric stroke due to thoracic outlet syndrome treated with thrombolysis and thrombectomy: a case report. Children. June 2022, 9, 875 (Case report).

Grace Onimoe, Dhanalakshmi Angappan, Marie Christianne Ravie Chandar and Sarah Rikleen. Effect of Covid-19 pandemic on well child care and vaccination. Frontiers in Pediatrics. April 2022, Vol 10, Issue; 10.3389/fped.2022.873482 (Original research).

Dhanalakshmi Angappan, Jitendra Sahu, Pratibha Singhi, Prahbhjot Malhi. Safety, tolerability and effectiveness of oral Zonisamide therapy in comparison with intramuscular adrenocorticotropic hormone therapy in infants with West syndrome, a randomized controlled trial. European Journal of Pediatric Neurology. Jan 2019. Vol 23 (1), 136-142 (Original article).